The Effect of Tracheostomy on Outcome and Resource Utilization in Trauma Patients at a Level I Trauma Center: An investigation with Propensity Score methodology and systematic review of the literature by Gant, Joshua
  Joshua Gant 
 
 
 
 
The Effect of Tracheostomy on outcome and resource utilization in trauma 
patients at a Level I trauma center, an investigation with Propensity Score 
methodology and systematic review of the literature 
  
 
 
By 
Joshua Gant 
 
 
A Master’s Paper submitted to the faculty of  
the University of North Carolina at Chapel Hill 
in partial fulfillment of the requirements for 
the degree of Master of Public Health in 
the Public Health Leadership Program. 
 
Chapel Hill 
2011 
          
__________________________ 
Advisor:  
              Date 
_________________________________ 
Second Reader:  
 Date 
   
  Joshua Gant 
 
 
 
 
Contents: 
1. Research Manuscript- The  Effect of Tracheostomy  on outcome and resource utilization 
in trauma patients at a Level I trauma center, an investigation using Propensity Score 
methodology 
2. Addendum: Limited Systematic Literature Review 
3. References  
4. Tables and Figures 
a. Table 1-5: Original Research 
b. Table A1-A7: Systematic Review 
 
  
  Joshua Gant 
Abstract 
Background 
The use of tracheostomy has long been an accepted option in patients requiring prolonged 
mechanical ventilation. As its use has continued to increase research has focused primarily on 
timing, investigating benefits of earlier use and how quickly it should be considered. Less focus 
has been placed on which patients it should be used for at all. Several recent studies that have 
investigated this question found none of the assumed survival benefit, with one even showing 
increased mortality in tracheostomy patients. With the need to better understand which patient 
populations do benefit more study of specific groups is needed. We studied survival and length 
of stay outcomes in mechanically ventilated trauma patients in a Level I Trauma Center Intensive 
Care Unit (ICU) to determine the utility of tracheostomy in this specific population.  
 
Methods 
 This retrospective cohort study of tracheostomy outcomes used data collected from the 
University Of North Carolina Hospitals Trauma Registry on adult trauma patients admitted 
between January 2000 and December 2010. All non-burn patients who were mechanically 
ventilated in the Surgical ICU for at least 24 hours were included for analysis. Patients who 
received tracheostomies were compared to all other included patients regarding survival to 
discharge. Time on mechanical ventilation and ICU and hospital lengths of stay were secondarily 
analyzed. Logistic regression was used in comparison of primary and secondary outcomes, and 
derived propensity score matching was used to adjust for confounding. 
 
Results 
Of 2489 patients meeting basic inclusion criteria 509 had tracheostomies performed. 
Prior to any adjustment tracheostomy was statistically significantly associated with greater 
survival to discharge (90% vs 76% OR 2.99, p<0.001). Logistic regression resulted in an odds 
ratio (OR) of 5.36 (P<0.001) and propensity score matching yielded an OR 3.84. ICU length of 
stay (tracheostomy mean 24.9 days, control mean 5.3) and hospital length of stay (mean 42 vs 
12.1) as well as time on mechanical ventilation (mean 20.4 vs 3.6 days) were all statistically 
associated with longer times for the tracheostomy group. Cost was similarly associated, with 
mean values $193,173 vs 66,174. 
 
Conclusions 
 Among trauma patients tracheostomy use was associated with greater survival to 
discharge, but also with longer mechanical ventilation time, ICU length of stay, hospital length 
of stay and cost. These relationships persisted with propensity score matching to minimize 
confounding by indication, suggesting a survival benefit from tracheostomy. Longer stays may 
result in part from lead time before tracheostomy and may be reducible by earlier 
implementation. 
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The Effect of Tracheostomy on outcome and resource utilization in trauma patients at a Level I 
trauma center, an investigation using Propensity Score methodology 
Introduction 
 Tracheostomy has long been an important option in the care of any patient requiring 
extended mechanical ventilator support, particularly in severely injured trauma patients, and its 
use is increasingly common. In North Carolina the incidence of tracheostomy for prolonged 
mechanical ventilation in 2002 was 24.2 per 100,000 patient years, increased from 8.3/100,000 
in 1993.1 With the development of less invasive percutaneous placement methods tracheostomy 
can be used without a trip to the operating room and there is continuing interest in possible 
improved outcomes when done earlier in the mechanically ventilated patient. However, the 
overall therapeutic advantage and indications have not been well delineated.  
In cases of upper airway obstruction, the need for tracheostomy is apparent, but in other 
cases, the assumed benefits offered over laryngeal intubation often originate in clinical reasoning 
and basic science physiology research rather than outcome oriented evidence. Several studies 
have suggested that tracheostomy use in mechanically ventilated patients can reduce airway 
swelling, improve dead space ventilation and significantly decrease work of breathing compared 
to prolonged endotracheal intubation 2-5 Physicians generally choose tracheostomy with the 
expectation of improved patient comfort, eased ventilator weaning and reduced risk of ventilator 
associated pneumonia.6 Studies on patient level outcomes have generally taken these potential 
benefits as a starting point and include only patients who receive tracheostomies. They focus on 
comparing placement early (often considered less than 7 days) versus late placement in 
mechanical ventilation,  with most demonstrating benefits of earlier tracheostomy including 
  Joshua Gant 
reduced intensive care unit (ICU) length of stay, easier weaning from ventilators, and reduced 
overall cost.7-9   
There is significantly less recent work directly comparing outcomes against prolonged 
use of a nonsurgical airway (endotracheal intubation). Even trauma departments with their 
frequent use of invasive procedures including tracheostomy do not have well defined indications 
to standardize tracheostomy tube placement. One large retrospective study of patients from the 
national trauma database found significant unexplained variations in use.10 Departing from the 
trend several more recent studies have investigated which patients would  have better outcomes, 
and amid increased efforts at cost reduction or containment, the determination of  decreased 
resource utilization including reducing ventilator days would be beneficial.11-13  
Attempting to explain variations in prior studies as well as unexplained differences in 
practice patterns that further confound these studies has been challenging. To account for such 
confounders, several studies used matching based on tracheostomy propensity scores derived in 
their cohort of unselected patients from the medical ICU, or in one case respiratory care center. 
Using propensity scores and other methods to address bias showed  little or no survival benefit in 
tracheostomy use and in fact post ICU patient care needs increased.11-13 Further exploration of 
recent relevant literature including a limited systematic review is presented in the Addendum. 
These results illustrate the uncertainties in current understanding of how to best use 
tracheostomy and the need for further study to determine which cohort of patients are more 
likely to benefit. The trauma population, underrepresented in these recent investigations, could 
benefit greatly from better understanding of the true balance of patient benefit with resource use. 
The acuity and severity of disease in trauma patients combined with typically better overall 
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premorbid health makes this a unique population in potential tracheostomy use.  The high cost of 
trauma care delivery makes it all the more important to avoid wasted resources.  
In order to delineate the effect of performing a tracheostomy on both cost and patient 
outcomes, we conducted a retrospective study of UNC Memorial Hospital trauma ICU patients. 
Widely variable patient populations within the trauma cohort and differing injury severity leave 
the indications for tracheostomy less well defined. Propensity score matching has been 
increasingly utilized as a means to adjust for confounding by indication and this methodology 
was utilized in our study. As such this study will use derived propensity scores to match adult 
ventilator dependent surgical ICU trauma patients and determine differences in survival, total 
charged fees and length of stay for trauma patients managed with and without tracheostomy. 
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Materials and Methods 
Study Design and Data Source 
This retrospective cohort study was conducted using data from the University of North 
Carolina Healthcare System Trauma Registry database to evaluate differences in outcomes 
between those with and without tracheostomy. This database, established to meet State and 
National reporting requirements, tracks all patients admitted to the UNC system Trauma, Critical 
Care and Acute Care surgical service at NC Memorial Hospital. This 800 bed Level 1 Trauma 
Center in Chapel Hill cares for greater than 2000 trauma patients each year.  The registry is 
maintained by trained Trauma Program staff facilitating the transfer of data from the hospital 
records system. The full list of data types it contains varies with researcher requests for further 
details, but the minimum data set includes basic demographic information, diagnostic and 
procedure codes, a range of severity scores and other statistics relating hospital stay including 
some billing information.   
The data is collected by hand from the various electronic medical record systems used in 
the hospital by the registry staff with basic information updated daily and protocols for quality 
assurance and data completeness are in place. Because this data is a de-identified limited data set 
from the trauma registry informed consent was waived. 
Population 
 This study uses registry data for patients admitted to NC Memorial hospital between 
January 2000 and December 2010. Our study cohort included trauma patients age ≥18 years that 
were mechanically ventilated in the Surgical Intensive Care Unit for at least one day. Burn 
patients were excluded for their greater potential for direct airway effects from their burns. From 
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this study population tracheostomy patients were identified by ICD-9 procedure codes 31.1 and 
31.29 for tracheostomy placement with the remaining providing the pool of controls. A total of 
2489 patients meeting these criteria were provided by trauma registry staff, and of that number 
509 had tracheostomies placed. 
Variables  
Basic demographic variables included race, age, insurance status and year of admission. 
Race was coded in 4 categories: white, black, Hispanic and other. It was later dichotomized into 
white and nonwhite patients for analysis. Age was represented in quartiles, with blocks of 18-26, 
26-38, 38-54 and over 54 years age. Payer status was coded for analysis as self-pay, Medicaid, 
worker’s compensation or other.  
Injury variables included mechanism of injury (blunt or penetrating), admission Glasgow 
Coma Scale (GCS), Abbreviated Injury Score  for body region (AIS) , Injury Severity Score 
(ISS) and acuity alerts at presentation under a yellow or red trauma alert system. GCS, a 
representation of responsiveness, was analyzed in a dichotomized form, split at a score of 9 as 
this is generally considered a cut off for severe deficits in consciousness and often head injury. 
Abbreviated Injury Severity (AIS) scores are given for head and neck, face, chest, abdomen, 
extremities and skin and range from 0 for no injury through severe at 4 and maximum or non-
survivable at 6. Injury Severity Scores (ISS) are a calculated composite score using the sum of 
the squares of the greatest 3 AIS body region scores. They are very commonly used to represent 
an overall level of injury in the patient.  ISS scores range from 0 to 75 and are automatically 
scored 75 if any regional AIS is given its maximum of 6. This score has been well correlated 
with mortality, morbidity and hospital stay as well as other severity measures.14 Because of this 
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derivative relationship AIS scores are presented for initial comparison, but are not used directly 
in modeling results.  
 Collected outcome variables were mechanical ventilation days, surgical ICU length of 
stay, hospital length of stay, and disposition (death or discharge). Total hospital charges at 
discharge were also included for analysis. These are only raw charges and not final billing 
information; however they give some indication of relative costs. In using the trauma registry all 
data is limited to that collected during the patient stay and so no information could be included 
beyond that point. 
Statistical Tests 
 Descriptive statistics are given as numbers or patients with percent of exposure group or 
means with 95% confidence intervals. Bivariate analysis of the unadjusted data was done using 
chi-square tests for categorical data and the Student’s T-test for normally distributed continuous 
data. These included age and ISS score. The Wilcoxson Rank Sum method was used for non-
normally distributed data including AIS scores, GCS and admission year. Two sided P values 
from respective tests are also given.  
We conducted initial bivariate analysis of outcomes with tracheostomy status using Rank 
Sum tests for the non-normally distributed length of stay data and chi-square testing for survival 
to discharge. We also utilized logistic regression to calculate survival odds ratios. We then 
developed a multivariate regression model for predictors of outcomes for comparison to 
propensity score matched results. All collected demographic data was included in the initial 
model along with GCS and ISS scores, mechanism of injury, trauma alert status, admission year 
and payer status of self-pay, worker’s compensation or Medicaid. As noted above, race was 
dichotomized as white and nonwhite, age represented by quartiles and GCS dichotomized as 
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severe (less than 9) or non-severe. We then refined these models dropping non-significant 
variables using p<0.05 as a cutoff for significance. We used Logistic regression for survival and 
Linear multiple regression for continuous variables (LOS and cost) to calculate a survival odds 
ratio and provide mean values for continuous variables with 95% confidence intervals. 
Normality of the distribution of residuals was checked graphically in each model. 
 To address the lack of standardized indications leading to increased chance of 
confounding, as well as normal risk of unaccounted confounding in a retrospective study, a 
propensity score for tracheostomy was developed. Discussions of advantages and potential 
limitations of propensity scores as well as detailed derivation methods and use can be found in 
several papers.15-18 Briefly, propensity scores provide a method of collapsing multiple potential 
confounders to a single score predictive of the exposure status. Any study subjects with 
equivalent propensity scores have the same theoretical chance of being in either exposure group. 
This leaves random chance or unmeasured confounders to explain any differences in assignment, 
and thus allows some approximation of randomization in a non-randomized study. We 
implemented propensity scores using the psmatch2 Stata package.19,20  
We developed the propensity scores starting with the same initial set of data used in the 
earlier regression study, though it is more important to retain even weaker associated variables in 
propensity scoring. Variables were dropped from the propensity score model when they were 
worsening the balance of the propensity score model. We used nearest neighbor matching within 
a 0.01 caliper with 3 unexposed controls per exposed patient leaving one exposed patient 
unmatched.  The Stata package was then used to match patients and calculate mean values with 
95% confidence intervals and p values for continuous outcome variables and probability of 
survival. Psmatch2 only matches patients with data complete for all included variables in the 
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model and outcomes. Because only charges values were not available for all patients they were 
calculated with a separate match, though it used the same model. We then calculated sensitivity 
analyses for each outcome using Rosembaum Bounds.21 We used the rbounds Stata package to 
implement this testing.22,23 The Rosenbaum bounds sensitivity analysis assumes a hypothetical 
unmeasured confounder for the outcome. It then calculates a predicted minimum magnitude of 
effect, Γ, that the unmeasured confounder must exert on the odds of a patient being in a 
particular exposure group to cause the true answer to fall outside the 95% confidence interval.  
Throughout analysis p<0.05 was used as a cut off for significance. All analyses were 
performed with STATA version 11 (StataCorp, College Station, Texas).   
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Results 
Study Population 
From the UNC trauma registry, 2489 patients met inclusion criteria for analysis with 509 
having had tracheostomies performed. Basic demographic information as well as injury related 
variables of both tracheostomy patients and controls are given in Table 1 for comparison along 
with p values for inter-group differences. Of note, age was significantly different between the 
groups with a larger portion of control subjects under age 30 (35.81%/28.68% p=0.003) and 
fewer over age 65 (14.55%/18.07% p=0.048). There was also a significantly higher portion of 
‘self-pay’ and lower Medicaid in the control group.  
Regarding injury characteristics, mechanism of injury, and portion of subjects with a 
GCS less than 9 all AIS scores and ISS scores each had significant differences by P value.  The 
control group had a larger proportion of its population with GCS scores below 9, but lower mean 
ISS score. The GCS score was unavailable for 154 of the unexposed and 48 of the tracheostomy 
patients. ISS was unavailable for 14 unexposed patients. Charges data was unavailable for 139 
exposed and 34 unexposed patients. 
Matching 
 As psmatch2 based propensity matching only includes subjects with complete data for all 
modeled variables 1812 of the 1980 control subjects and 461 of the 509 tracheostomy patients 
were candidates for matching.  This is the result of the missing ISS and GCS data noted above. 
One tracheostomy patient was left unmatched, with 461 trauma patients matched to 3 controls 
each. In examining the hospital charges variable, there was a further loss of complete data sets 
bringing the matched totals to 1716 control and 428 tracheostomy patients. The variables used in 
the propensity score derivation are shown in Table 2, along with the calculated bias of their mean 
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values and the p value of this bias between treatment groups before and after matching. All 
variables had significantly reduced bias and were no longer statistically significant after 
adjusting with matching. 
Outcomes 
Unadjusted results from simple bivariate analysis appear in Table 3 and show strongly 
statistically significant differences between the unexposed and tracheostomy groups for each of 
the outcomes. For survival to discharge tracheostomy patients had a 90% survival rate compared 
to 76% in unexposed patients, equating to a survival odds ratio of 2.99 for tracheostomy patients 
over unexposed. The hospital length of stay, days spent on mechanical ventilation and total days 
in the ICU were all significantly higher for tracheostomy patients. Hospital stays averaged 42 
days for tracheostomy vs 12.1 for controls. Similarly mean mechanical ventilator times were 
20.4 and 3.6 days and ICU length of stay was 24.9 and 5.3 for exposed and control patients, 
respectively. Total charges averaged $193,173 versus $66,174 for intervention and control 
groups, respectively.    
Using the multivariate logistic regression model to adjust for confounding resulted in 
only minor changes shown in Table 4 to the mean ICU and hospital length of stay, mechanical 
ventilation time or charges. Adjustment did significantly strengthen the association of better 
survival odds and tracheostomy with the survival odds ratio increasing from 2.99 to 5.36.  
Implementing propensity score matching differences in the independent variables 
between exposure groups were greatly reduced in the matched model as seen in Table 5. The 
change to outcomes was strongest in the control group, with  mean length of stay rising from 
12.05 to 13.56 days, ventilator days from 3.66 to 4.3 days, ICU days from 5.37 to 6.14 days, and 
charges from $66,607 to $75,482. Change to survival odds from univariate to propensity 
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matched analysis was more modest than the change from the regression model, though it still 
increased the odds ratio from 2.99 to 3.84 in favor of tracheostomy patients.  
Rosenbaum bounds sensitivity analysis of this model showed that an unaccounted for 
confounder would have to bias subject exposure status by an odds ratio of 15 for length of stay or 
15.1 for ventilator days to be outside the 95% confidence interval and 17.9 to have an effect on 
the number of ICU days. Though still fairly resistant to unmeasured confounding, charges and 
survival are more sensitive at 9.5 and 4.2. 
 
Discussion 
 Our study shows a significant association with greater ICU and overall Hospital survival 
in those mechanically ventilated trauma patients who underwent tracheostomy.  With the 
survival odds 3 times as high before any adjustments and a greater association after controlling 
for selection bias this is a strong result, and may be a result of a combination of factors. We 
hypothesize one major factor in this result is the acute nature of the critically ill trauma patient, 
making them fundamentally different in their response to tracheostomy compared to the broader 
ICU populations in most other tracheostomy outcome studies. In the acutely injured setting, it is 
likely they need only a limited intervention to bridge them through the worst of their respiratory 
compromise to begin recovery than the population of a general ICU.  
One such study, Clec’h mentioned above, challenged typical assumptions of benefit in 
tracheostomy and found statistically significant association with higher mortality for 
tracheostomy patients. Our finding of a survival benefit is consistent with most previous studies 
addressing tracheostomy outcomes in general ICU populations.12,24-27 Interestingly, though, these 
studies including Clec’h et al generally showed demographics suggesting less sick patients were 
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selected for tracheostomy. In our study, though, while some differences were mildly non-
significant our population tended toward more tracheostomy patients having GCS<9, penetrating 
injuries, greater abdominal injury and more were admitted as Yellow or Red traumas with 
suspicion of greater injury leading to the movement away from the null with adjustment. 
This suggests that selection bias itself likely works differently in different populations. 
Even after propensity score adjustments for causes related to survival, some of the benefit is 
likely still due to differences between treatment and nontreatment groups. That chance to bridge 
patients through the worst of a secondary illness may lead treating physicians’ selection of 
tracheostomy patients to be based more on their experience with patients who do at least make it 
past their respiratory compromise. If true, this provides some support for current tracheostomy 
decision making practices, at least in trauma patients. 
One small recent study by Barquist et al did focus on trauma patients and used 
randomized treatment assignment, but found no differences in any outcomes. However, this 
study was stopped prematurely and only totaled 62 patients. Additionally, 11 of the 31 patients in 
the arm not to receive tracheostomy any earlier than day 28 crossed over and received the 
intervention, moving results toward the null.28  
 These differences do become limitations to generalizability. As well as a focus on trauma 
patients alone, this study population is derived from a single institution, a Level 1 trauma center 
which sees many severely injured trauma referrals from outside hospitals. This is a very different 
picture from the majority of hospitals needing to decide on tracheostomy use. Even between 
trauma centers, the study’s mix of 90% blunt injured patients is very representative of region 
UNC covers, but this make-up varies significantly among different regions. 
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Our results finding increased survival, though, are tempered by longer times spent on the 
ventilator, in the ICU and in the hospital in general along with higher costs. Even adjusted for 
initial level of illness to be more similar tracheostomy patients had significantly greater time 
spent not only in the hospital (mean 42 vs 13 days) but in the ICU (24.9 vs 6 days) and on 
mechanical ventilation (20.3 vs 4.3). The difference in hospital and ICU stay lengths appears 
primarily driven by longer mechanical ventilation times. One cause of longer ventilation times 
may be the higher mortality of non-tracheostomy patients, with early deaths lowering aggregate 
stay times. As well, before receiving a tracheostomy most patients would have spent varied time 
on a mechanical ventilator. Thus, even if weaned from the ventilator the same day the 
tracheostomy was placed these patients may have an extended period of ventilation time due to 
delays in tracheostomy placement. A weakness of this study, it is unfortunately not possible to 
investigate this with our data, as timing of tracheostomy was not included. 
This limitation of available data is inherent in our use of registry data. As the database 
was designed first as a system for reporting and quality control, timing of the tracheostomy 
relative to intubation or the start of mechanical ventilation are simply not available. Even where 
the variables are available, they are at times not collected in categories that are useful for this 
research case. The inclusion of time before tracheostomy, DNR status and a better picture of 
general health of the patient before the injury could strengthening the adjustment for 
confounding as well. 
Because of this lack of information on when tracheostomy took place, it is difficult to 
draw an overall conclusion on resource utilization. This is, however, an important question to 
consider, illustrated by the significant association with higher cost for tracheostomy patients that 
results from longer times in the ICU among other factors, a result consistent among most studies 
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assessing this outcome.11,24,26 In the light of a medical system in need of lowering expenses, 
spending 5 times as long on mechanical ventilation must be carefully considered. Study of ICU 
and mechanical ventilation costs found the mean stay of 14.4 days costing over $31,000 for 
mechanically ventilated ICU patients, and less than $13,000 over 8.5 days for those not needing 
this level of support. Importantly, daily costs were greatest on the first ICU day with it costing 
$10,794 for mechanical ventilation patients ($4796 without) and by day 3 stabilized at 
approximately $4000 daily ($3200 without mechanical ventilation).29,30   
These costs first highlights the importance of further study focused on more specific 
populations, or powered for subgroup analysis to find which patients benefit from tracheostomy. 
These findings are most generalizable within the scope of trauma patients, though it does lend 
support to other studies that there is likely true benefit in some populations. Beyond this, our 
study is also limited in the same way any non-randomized trial of tracheostomy will be. Though 
indications may be better defined in some studies than others, there will always be some 
influence from expectation of outcomes in real world practice. A truly randomized controlled 
trial of significant size would, though difficult to achieve, be the greatest benefit in finding the 
true benefit of tracheostomy.  
The cost of mechanical ventilation also underscores the important of ongoing studies to 
determine the best timing of tracheostomy. If its earlier use is in the right patients is, indeed, able 
to decrease ventilation time it may greatly reduce cost difference findings. Tied to this, even 
when concerned primarily with overall benefit of tracheostomy as was our work, information on 
timing of tracheostomy will allow much better understanding of any benefit it may have in 
resource use. In all, this work to find the patients who benefit from tracheostomy has great 
implications in reducing costs of trauma and other intensive care.  
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Conclusion 
 In the context of other current research on tracheostomy outcomes, this study provides 
significant support for the survival benefits of tracheostomy use in the right patient population, 
bridging some of the knowledge gap between previous positive studies and newer studies 
showing it may not always help.11 It begins with a population with perhaps the most basic 
reasons to benefit from tracheostomy for studies into other specific patient groups to continue 
exploring which patient characteristics predict when tracheostomy can be useful. It also 
underscores the costs this care incurs, and wastes if improperly targeted. Critical care is an 
expensive field with determination of patient benefit often illusive in the complexity of the care, 
but work to understand when to use each of the tools available is an important focus. 
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Systematic Review 
To better place this study in the context of the current understanding of the use of 
tracheostomy we conducted a focused systematic review of recent literature. The review 
investigated findings on benefits and costs of tracheostomy in critically ill patients in literature 
from the last 10 years, focusing on mortality and length of stay. A subjective summary of the 
overall evidence of tracheostomy in recent years will then be made.  
Methods 
Search Strategy and Selection 
Initially the Medline MeSH term database was used to identify appropriate MeSH terms 
relating to tracheostomy and mechanical ventilation. From this, the terms “tracheostomy”, 
“intensive care units”, and “respiration, artificial” were selected. On examining results the 
alternate forms “tracheotomy”, “intensive care” and “critical care” were added to the search. As 
there is a delay in adding MeSH terms the above terms were also searched without limiting to 
MeSH results. Filters were applied to all searches limiting results to only human adult 
populations with English language publication in the last 10 years. To best address the question 
only those studies with control groups not undergoing tracheostomy and a sample size at least 
200 were included. Related to this, studies focused on timing of tracheostomy rather than 
benefits of tracheostomy were not included. 
 Using this search strategy resulting articles were first reviewed by title, with those 
clearly not meeting the above criteria excluded from further analysis. Abstracts of the collected 
articles were then reviewed and those with only intermediate outcomes including change in 
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respiratory effort were not included. PubMed cited and related works were then examined and a 
hand review of references was done to find any further papers meeting criteria. 
Data Abstraction 
Abstraction of study data was conducted by the reviewer. A pre-determined set of data 
was collected from each paper covering basic study characteristics as well as outcomes. 
Characteristics included study design, source and study population, study population 
demographics, inclusion and exclusion criteria, and type of analysis done. Outcomes of interest 
were those relating mortality or hospital or ICU length of stay.  
Analysis 
All included studies were analyzed using pre-determined standardized quality measures. 
These quality measures include likely risks to both internal and external validity and represent 
the general strength of methodology. Source population definition, appropriateness of the study 
population and analysis methods, overall quality and generalizability were rated poor, fair or 
good. Potential for selection bias, measurement bias and uncontrolled confounding were rated 
low, moderate or high. Due to heterogeneity of populations and outcomes measurement no 
combined analysis of results was done. 
Results 
Initial database searches within PubMed using both MeSH and non-MeSH terms but not 
yet limited by study age yielded 277 potential articles. Of those, 169 were published in the last 
10 years. An initial screen of article relevance by title narrowed the result to 14 studies that may 
meet inclusion criteria. A review of the abstracts excluded 7 of these articles for their focus on 
intermediate outcomes or tracheostomy timing. A further 2 articles were excluded based on size. 
These 2 articles, n= 60 and n=122 both had non-statistically significant results for measured 
  Joshua Gant 
outcomes.13,28 The 5 articles that remained were pulled in full text and reviewed to confirm their 
relevance.11,12,25,26,31 
Summary Characteristics 
 Study characteristics abstracted from each paper are discussed below, and were compiled 
and presented in Table A-1, with basic patient demographics following in table A-2.  In 
summary, of the included studies 2 were retrospective12,26 and the others prospective. Three 
studies were conducted at single centers12,26,31 while 2 involved multiple centers. All studies 
collected similar basic demographic information along with a variety of disease severity 
indicators. ICU and total hospital mortality were primary outcomes for all 5 studies. ICU length 
of stay and days of mechanical ventilation were primary outcomes for 2 studies25,26 and 
secondary for the others. Hospital length of stay was not given in 2 studies26,31 and secondary in 
the others. These results are also discussed with each paper and compiled in tables A-3 through 
A-6. Finally, evidence quality ratings are presented in Table A-7. 
Mortality, Length of Stay and Mechanical Ventilation times 
 Of the 5 included studies 3 found a lower ICU mortality rate associated with use of 
tracheostomy. Though Flatten et al does not give statistical significance measures Combes et al 
and Frutos-Vivar et al both show statistical significance in adjusted scores.25,26,31 The paper by 
Clec’h et al does show statistically significant association with lower mortality (OR 0.65) in the 
unadjusted model. However, the propensity score matched models in fact shows an association 
with higher mortality that is statistically significant (OR 2.57).11 The study by Wu et al did not 
give a direct comparison of mortality in the critical care setting, but rather the percentage of 
overall deaths that occurred in the RCC. This showed no significant difference between groups 
with or without adjusting. 
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 Tracheostomy was found to be associated with lower hospital mortality in Combes, Wu 
and Flaaten. Flaaten gives no statistical significance indicators, while Wu and Combes show 
statistical significance.12,26,31 Frutos-Vivar et al did not find significant differences between 
populations in hospital mortality. In the case of Clec’h  the results is given in more detail by 
breaking down propensity adjusted post ICU mortality to show all patients, those decannulated 
before discharge from the ICU and those discharged with a tracheotomy. Post ICU patients 
discharged after decannulation showed no association with mortality, while there was a statistical 
association of tracheostomy with higher mortality in both those patients discharged from the ICU 
without decannulation and all patients post ICU. 
 Examining ICU length of stay and days of mechanical ventilation there was a consensus 
of strong statistical association between tracheostomy and greater lengths for all each 
outcome.11,12,25,26,31 Except for the lack of data from Flaaten and Frutos-Vivar, the same strength 
of association is present for greater overall hospital length of stay in the 3 studies which do 
include it. 
Quality Evaluations 
 Each included study has strengths and weakness, but all studies in this subject area have 
one prominent issue in common. This is the baseline selection bias, sometimes referred to as 
confounding by indication, inherent in non-randomized care decisions about tracheostomy. As a 
potentially morbid and costly procedure the more unstable patients would be less likely chosen 
for tracheostomy directly because they are more likely to die no matter the treatment, leaving the 
control group with sicker patients. This may even be increased by observation effects, with 
clinicians not wanting to report high mortality rates related to tracheostomy and taking what they 
deem a less risky approach. This bias would tend to increase any apparent survival benefit or 
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lessen any harm and would be increased by the inconsistent and poorly defined indications 
common to use of tracheostomy.  
 Similarly common in its effects, the importance of measurement bias is dependent on 
what non-primary interest variables are used for. Though the outcomes of interest in this review, 
mortality and lengths of time, are less likely to be misreported systematically others such as 
injury severity and indications may be more open to bias. If these are used to adjust for possible 
confounding, they could skew the adjustment. 
 One other characteristic affecting all included studies, their geographic settings, has some 
effect on their generalizability between each other. Two were conducted in France, one in Japan, 
one in Norway and one with data gathered across multiple countries. Due to system differences 
in intensive care units and the post ICU stay as well as differences in patients populations 
admitted to ICUs, there may be some effect on the applicability of these papers to practice 
outside their country of origin.  
 The study by Clec’h et al was a prospective observational cohort conducted using a 
database made up of patients from 12 ICUs. This database, OUTCOMEREA, is selected from 12 
French ICUs and contains only patients at least 16 years of age with ICU stays of at least 24 
hours. The sample was done randomly with the selection method chosen by each institution to be 
either: consecutive patients in N random chosen beds or consecutive admissions in a randomized 
month. Their definition of the source population is adequate, but it should be noted that it is a 
relatively diverse and potentially heterogeneous population. Nothing is noted of the types of 
institutions making up this database. As the authors exclude only repeat tracheostomy and 
include all patient from the database ventilated at least 48 hours this should be well 
representative of the source.  
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Of the 2186 patients included in the study, 177 had tracheostomies placed. Patients were 
primarily respiratory medical patients (approximately 70%) with surgical patients making up 
23% and 34% of the tracheostomy and control groups respectively. The authors note that all 
participating ICUs followed recommendations of the Societe de Reanimation de Langue 
Francaise for airway management and weaning protocols. This should lessen the likelihood of 
inconsistent practices between the many participating institutions. Additionally they place 
particular focus on adjusting for this selection bias. Their use of 2 methods of building the 
propensity score model leads to their low probability of selection bias and analysis rating of 
good. There may still be some uncontrolled confounders but this method, already discussed in 
the research manuscript, should lessen their effects. Finally, the lack of blinding of data 
collectors or clinicians could result in some measurement bias. As already stated, this is unlikely 
to effect the direct data of interest, but the propensity score is based on more potentially 
subjective or miss-stated data. This should be minimized, though, as all data is collected through 
a standardized form into a database established for much wider goals. The disadvantage of using 
a wider database for collection does show some effect by their lack of several variables identified 
as pertinent as they built their propensity score model. 
Overall, as the authors initiated this study with the hypothesis that bias was behind some 
previous results, their use of good statistical methods leads the study to have an overall “good” 
strength of evidence. Generalizability is more difficult, though. The study is done in a number of 
institutions but it is difficult to say where it can be generalized to without further investigation of 
the institutions feeding the database. It may be reasonably generalizable to French ICUs but with 
system differences it may be difficult to directly apply elsewhere. In showing a well-supported 
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result countering standard assumptions, the need to better define which patients do benefit is well 
illustrated. 
The second prospective observational cohort included study included, by Flaaten et al, 
draws its patients from a 10 bed closed ICU in a 900 bed Norwegian University Hospital. The 
authors provide a very well defined source population, describing the operation of the ICU and 
allowing a clear picture of what patients could have been included in the study. Including case 
mixes and demographics of the ICU by year furthers this understanding. From this, the study 
population is made up of those who were mechanically ventilated at least 24 hours between 1997 
and 2003. This inclusiveness should well represent the source population. Of 2844 admissions 
507 patients had tracheostomies placed and 855 made up the control group. Indications used for 
these tracheostomies are specifically stated, though they still leave room for bias to effect 
treatment leading to the moderate to high risk or selection bias. 
The greatest weakness in this study, though, is the analysis of the data. Significance is 
shown for mean ventilator days and ICU days by 95% confidence intervals. However, though 
mortality is mentioned as a primary focus of the study there is no data given on statistical 
significance. Further analysis is given for general demographics but without indication of 
significance of mortality results they are of limited utility. As well, there is no analysis presented 
adjusting for confounding leading to its rating of high probability of confounding effects and 
‘poor-fair’ internal validity. The same rating is given to generalizability as it is difficult to 
determine the true internal validity. 
The third study reviewed here by Combes et al is a retrospective cohort with a nested 
matched case control. Here the source population included all patients admitted to the authors’ 
18 bed tertiary care ICU between 2002 and 2004. This gives a reasonable definition of where the 
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study population comes from, but receives a fair as there is no information provided to 
characterize it further. As to study population, there are 2 to be considered. The primary study 
population is that of the main cohort study. This study population includes all patients needing 
mechanical ventilation greater than 3 days of mechanical ventilation who were did not have 
tracheostomies in place at admission to the ICU. Of the 1629 patients admitted to their ICU 
whom 506 were included in the study, with 166 receiving tracheostomies. It would have been 
helpful to know how many were excluded because of a tracheostomy in place on admission to 
better understand the makeup of the usual patient in their ICU, but with no other exclusion 
criteria this should properly represent the applicable patients. The second study population to 
consider is the nested case-control, as they were only able to match 120 of the 166 tracheostomy 
patients to one control each. Those left unmatched are likely systematically different, perhaps 
most likely sicker. The effect this has may be limited as the authors do state that there was no 
statistically significant difference in mortality between those patients included and not included 
in the match but this does lessen the representation of the source population. 
This nested cohort does provide this study’s effort to deal with selection bias. The 
decision to tracheostomize a patient is done by clinical consensus of ICU Intensivist at daily staff 
meetings and indications used are specifically given. There is some room for the same baseline 
selection bias here, with patient likelihood to survive having some influence on determining need 
for prolonged intubation. This appropriately matches patients by derived propensity scores, as in 
Clec’h et al and overall leads to the analysis being rated ‘good’ and probability of selection bias 
in the case-control results being low-moderate. The well described matched subset should also 
make the risk or uncontrolled confounders fairly low, though with the limited data of a chart 
review paper some risk remains. 
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As a retrospective study this paper gathered results through chart review. This leaves it 
open to some risk of measurement bias. The authors describe when in the course of an admission 
the data was entered into the chart system, but provide no information of the type of database 
used or who enters the data. The data used is fairly objective, though, and any error in 
measurement is unlikely to be systematic. 
Overall this study was given a “Fair-good” internal rating as there is some question of 
how representative the better analyzed case control subset is of the source population, but the 
general methodology is relatively well done. From this, generalizability was also rated “Fair-
good” for patients mechanically ventilated at least 3 days. As with the Clec’h study this is done 
in a French ICU setting, making their results somewhat more comparable to each other than 
other studies. 
The next of the studies is also the largest, the multi country prospective cohort study by 
Frutos-Vivar et al. This study includes patients from 361 ICUs from 12 countries including the 
United States, Canada and other in Europe and Latin America. The authors do not, unfortunately, 
describe how these ICUs were selected for participation and the very wide range of populations 
this study draws from makes a well-defined source population beyond the described study 
population difficult or impossible. Within the study population, though, there is a fairly good 
description of the types of patients that make up the combined group as well as some descriptive 
statistics showing differences between regions. The study population likely represents the source 
population as a whole, but the heterogeneity makes applying results to any individual location 
somewhat more difficult. As well, the authors acknowledge the risk of selection bias in any study 
of tracheostomy, a challenge made more difficult to control for by the large scale. The presence 
of this bias here is supported by the differences in given indications for mechanical ventilation 
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between patient groups. The patients with tracheostomy were significantly more likely to have 
had a previously normal functional status, more likely to be in a coma, and more likely to have 
neuromuscular disease or be trauma patients. These differences have a mix of likely results, and 
also suggest other differences in groups that went unmeasured. However, they also do not have a 
strongly apparent pattern of effect, with some such as neuromuscular disease likely increasing 
tracheostomy patients length of stay while others such as trauma as a primary admitting 
diagnosis may diminish it. This leads to the rating of moderate risk of significant selection bias. 
For the same reasons, with the lack of standardization and limited control, measurement 
bias must be rated a moderate possibility with its use for linear analysis. The analysis itself, 
however, is appropriate and though the logistic regression done is not as thoroughly derived as 
some propensity models it still gives the paper a fair-good internal validity. Applying the results 
is complicated by the heterogeneity of the study base. General conclusions are likely applicable 
with the strong result in ICU mortality and length of stay differences, however the null result 
from hospital mortality is as likely to be on either side of null in a given system. Because of this, 
overall generalizability is rated fair. 
The last retrospective cohort, by Wu et al, examined respiratory care center patient 
records at a Taiwanese tertiary medical center between November 1999 and December 2005. 
The authors describe the respiratory care center, its staffing and weaning methods, and the 
categorization as a respiratory care center narrows its patient base, making this easier to 
understand. Eligibility for the center was based on meeting National Health Insurance 
requirements including hemodynamic stability, no vasoactive drug infusions in the previous 24 
hours, stable oxygen requirements, no hepatic or renal failure in the previous 2 weeks or if the 
attending physician deemed it beneficial to be transferred to the RCC. From this well-defined 
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group all patients mechanically ventilated at least 3 weeks before respiratory care center 
admission were admitted if any previous weaning attempts had failed. Patients were excluded if 
they had terminal cancer or if they already had a tracheostomy placed prior to admission.  These 
should leave a fairly representative population, though it makes results of limited use in cancer 
patients. 
Of the patients remaining with after exclusion of terminal cancer patients 985 had 
received tracheostomies and 227 were maintained on translaryngeal intubation. The underlying 
selection bias in this study is apparent from the demographic data table, showing statistically 
significant differences in gender, origin (transfer from MICU), APACHE II score, reason for 
ventilation, ICU ventilation days, modified GCS, PImax, PaO2/FIO2 and BUN levels. Generally 
the patients who did not receive a tracheostomy had worse scores and were more likely 
transferred from the MICU. To address this the authors use a matched analysis which shows well 
matched groups, though it only includes 129 tracheostomy and 129 translaryngeal patients. As a 
result of the small portion matched, this analysis becomes a much less representative study 
population. 
Finally, the matched analysis likely controlled for most confounding, but as the authors 
note it may still have left some. The unmatched but more representative population showed 
strong signs of confounding. The study was given a rating of ‘Fair’ overall as its results may be 
of use in understanding tracheostomy, but they must be carefully considered. While length of 
stay and mortality both shifted, none of the outcomes changed direction and had only small 
change to significance of the result. This may justify the consideration that most likely what 
confounding is present was not enough to invalidate the result.  
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As to generalizability with the other studies, not only is this a very different setting, in a 
Taiwanese hospital, but it is a specialized respiratory care center. This would create a patient 
population significantly different from that of a general ICU, with more chronic and refractory 
problems. Few patients would only need a short bridge of mechanical ventilation, and any of 
those are left out by the requirement for 3 weeks of previous mechanical ventilation. This study 
must be applied primarily to patients with similarly longer term respiratory compromise when 
considering benefit. 
Discussion 
With the range of study setting and quality present in the 5 included studies it is useful to 
begin from a point of agreement. All 5 studies showed statistically significant associations with 
longer hospital and critical care length of stay, and the 3 that reported mechanical ventilation 
time showed the same in that case. As none the included studies were randomized they are all 
certainly harmed by some selection bias, but several do strong analysis attempting to control for 
this as possible. Because of this it seems reasonable to believe the results as a whole, though they 
can lead to further research as well. With the very different patient populations, this consistency 
gives the group of papers more generalizability than any individual result had.  
The results here also agree with several older studies including Kollef et al and 
others.24,27,32 While some patients may, in fact, have weaning times and ventilation times reduced 
if treated given a tracheostomy as is often cited33 as a reason for its use, this did not appear to 
hold true for the general population of mechanically ventilated ICU patients in these studies.  
Some of the increased ICU stay length may result from difficulty placing tracheostomy patients 
outside of an intensive care environment in some institutions, but in light of the increased 
mechanical ventilation times it is also likely related to continued failure to wean. 
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Results of mortality outcomes are more mixed. The 3 studies finding a protective effect 
of tracheostomy in ICU mortality; Flatten et al, Combes et al and Frutos-Vivar; are balanced by 
the work of Wu et al and Clec’h et al. Though Wu finds no significant difference in the ICU, this 
study is the only one to analyze it as a portion of total hospital mortality. As discussed below 
there is lower total hospital mortality in the tracheostomy patients in Wu et al, and so there was 
in fact a lower mortality rate in the ICU time as well. This comes without direct indication of 
statistical significance, however. Clec’h et al also found statistically significant ICU survival 
benefit for tracheostomy prior to adjusting. Once matched by propensity score, though, there is 
no evidence of difference.  
In the case of hospital mortality it must first be noted that Clec’h et al, like Wu in the 
previous outcome, is an outlier in reporting. This study reports reports post ICU mortality for its 
adjusted findings, while the others analyze overall hospital mortality. Clec’h does report 
unadjusted overall hospital mortality, but relies on propensity adjusted scores for main 
conclusions. In that light, studies by Combes et al, Wu et al and Flaaten et al. reported a 
protective association with tracheostomy on hospital mortality, with Frutos-Vivar finding no 
significant difference. Without adjustment Clec’h found no association, but once adjusted by 
propensity score, there was again a shift to worse outcomes by tracheostomy patients, finding 
statistically significantly higher post ICU mortality.  
The drastic difference found by Clec’h in both mortality differences after adjusting for 
selection bias may support their claim that much of the apparent survival benefit found by other 
studies is artifact of patients more likely to survive from the start. It is of particular interest that 
Clec’h et al was a multi-center trial in French ICUs, with Combes also based in a French ICU 
with a source population appearing relatively comparable in level of sickness and reason for 
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admission. Further, both used propensity scores to attempt to counter selection bias. Clec’h, 
however, was able to match a much greater portion of the tracheostomy patients (160-169/177 
compared to 120/166).11,26  
Considering all results, it is difficult to draw strong conclusions on ICU mortality. It 
seems likely that there are populations which may survive the ICU better with tracheostomy, but 
it is also apparent that strong selection bias is in effect in any non-randomized decision to 
employ tracheostomy. Though it has deleterious effect on determining benefit from 
tracheostomy, or if any patients not receiving tracheostomy because of selection bias would 
benefit, it at least shows that patients having much higher use of expensive ICU and mechanical 
ventilation time do survive more often.  
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Table 1: Basic subject characteristics 
  No Tracheostomy Tracheostomy Done   
  Total or 
Mean 
Percent 
total or 95% 
CI 
Total or 
Mean 
Percent 
total or 
95% CI p(tTest) 
Total: 1980 79.55% 509 20.45%   
Gender           
--Male 1466 74.04% 378 74.26% 0.918 
--Female 514 25.96% 131 25.74%   
Race-           
--White* 1140 57.58% 310 60.90% 0.174* 
--Black 497 25.10% 126 24.75% 0.291 
--Hispanic 213 10.76% 41 8.06%   
--Other 130 6.57% 32 6.29%   
Age 41.74 40.9-42.6 44.7 43.1-46.4 0.0018 
-under 30 709 35.81% 146 28.68% 0.003 
-over 65 288 14.55% 92 18.07% 0.048 
Age by Quartile         0.004 
<26 523 26.41% 100 19.65%   
26-38 490 24.75% 119 23.38%   
38-54 498 25.15% 143 28.09%   
>54 469 23.69% 147 28.88%   
Payor           
--Self 711 35.91% 131 25.74% <0.001 
--Workers Comp 68 3.43% 22 4.32% 0.351 
--Medicaid 272 13.74% 87 17.09% 0.055 
admission year 2005.3 
2005.12-
2005.392 2004.7 
2004.72-
2004.99 0.0004 
Mechanism of 
Injury:           
--Blunt 1750 88.38% 464 91.16% 0.075 
--Penetrating 230 11.62% 45 8.84%   
Trauma Alerts           
--Red 1528 77.17% 396 77.80% 0.763 
--Yellow 233 11.77% 44 8.64% 0.545 
GCS*** 5.1 4.9-5.3 5.4 5.1-5.8% 0.1183 
--GCS<9 1276 64.44% 302 59.33% 0.09 
AIS (geometric 
mean)           
--Head/Neck 3.4 3.36-3.49 3.7 3.62-3.86 <0.0001 
--Face 1.9 1.82-1.94 1.9 
1.722-
1.95 <0.0001 
--Chest 3.1 3.02-3.14 3.2 3.09-3.33 <0.0001 
--Abdomen 2.7 2.59-2.73 2.6 2.48-2.70 0.0468 
--Extremities 2.6 2.50-2.66 2.6 2.52-2.62 0.0047 
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--Skin 1.2 1.10-1.13 1.1 1.10-1.17 0.032 
ISS 21.3 20.7-21.8 26.3 25.327.8 <0.0001 
*P value for dichotomous white/nonwhite 
**Geometric mean and ranksum P 
***Missing data for: 154 nontracheostomy, 48 tracheostomy 
 
Table 2: Propensity model variable response to adjustment, p<0.0001 
    Mean %bias % bias reduction 
t-test 
Variable Sample Treated Control t p 
trach Unmatched 1 0 .   . . 
  Matched 1 0 . . . . 
agequart Unmatched 1.6486 1.4443 18.5   3.52 0 
  Matched 1.65 1.6857 -3.2 82.5 -0.48 0.628 
racew Unmatched 0.60954 0.58168 5.7   1.08 0.278 
  Matched 0.6087 0.61889 -2.1 63.4 -0.31 0.753 
moi Unmatched 0.9154 0.88466 10.3   1.89 0.059 
  Matched 0.91522 0.94032 -8.4 18.3 -1.46 0.146 
gcs9 Unmatched 0.6551 0.69702 -9   -1.74 0.083 
  Matched 0.65652 0.66727 -2.3 74.4 -0.34 0.733 
iss Unmatched 26.735 21.389 45.7   8.65 0 
  Matched 26.63 26.888 -2.2 95.2 -0.34 0.735 
selfpay Unmatched 0.2603 0.36203 -22.1   -4.13 0 
  Matched 0.26087 0.2684 -1.6 92.6 -0.26 0.798 
workcomp Unmatched 0.04338 0.03422 4.7   0.94 0.346 
  Matched 0.04348 0.04466 -0.6 87.1 -0.09 0.931 
medicaid Unmatched 0.16703 0.13687 8.4   1.65 0.099 
  Matched 0.16522 0.14619 5.3 36.9 0.79 0.431 
year Unmatched 2004.8 2005.4 -16.8   -3.24 0.001 
  Matched 2004.8 2004.9 -0.6 96.6 -0.09 0.932 
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Table 3: Bivariate Outcomes 
  No Tracheostomy Tracheostomy p 
  Mean SE 95% CI Mean SE 95% CI   
Hospital Length of 
Stay (days) 12.1 0.34 
11.46-
12.77 41.98 1.51 39.0-45.0 <0.0001 
Days on Ventilator 3.6 0.11 3.4-3.9 20.4 0.89 18.7-22.2 <0.0001 
ICU days 5.3 0.14 5.0-5.6 24.9 0.96 23.0-26.8 <0.0001 
Total Charges($)* 66174 1552.7 
63128.75-
69219.16 195173.9 6012.84 
183358.7-
206989  <0.0001 
Survival to 
Discharge               
number 1501   75.81% 460   90.37% <0.001 
probability 0.76 0.0096 0.74-0.78 0.9 0.01309 
0.875-
0.929% <0.0001 
Odds ratio    2.99 0.48 2.2-4.1 p<0.001 *Missing data: No trach 105, Trach 34 
 
 
 
Table 4: Adjusted Regression Models Outcomes 
  No Tracheostomy Tracheostomy p 
  Mean SE 95% CI Mean SE 95% CI   
Hospital Length 
of Stay 12.4 0.47 
11.48-
12.33 40.58 0.95 
38.72-
42.44 <0.0001 
Days on 
Ventilator 3.87 0.23 3.41-4.32 19.46 0.47 
18.55-
20.38 <0.0001 
ICU days 5.61 0.26 5.10-6.12 23.92 0.53 
22.88-
24.96 <0.0001 
Total Charges 
($)* 68672.41 1880.88 
64985.96-
72358.87 187423 3822.94 
179930-
194815.7 <0.0001 
Survived to 
Discharge 0.792 0.065 
0.77-
0.81% 0.95 0.18 
0.933-
0.966 <0.0001 
Odds Ratio, 
+trach    5.36 1 3.7-7.7 <0.001 
*Missing data: No trach 105, Trach 34 
 
Table 5: Propensity matched Average Treatment on Treated (ATT)  and reference unmatched 
numbers 
  Sample Treated Controls Difference S.E. T- Sensitivity 
  Joshua Gant 
stat Γ 
Hospital 
Length of 
Stay  
Unmatched 42.00 12.05 29.95 1.06 28.14   
ATT 42.01 13.56 28.45 1.70 16.72 15.00 
Days on 
Ventilator 
Unmatched 20.29 3.66 16.63 0.52 31.72   
ATT 20.25 4.30 15.95 0.95 16.78 15.10 
ICU days Unmatched 24.88 5.37 19.51 0.60 32.70   ATT 24.85 6.14 18.71 1.05 17.86 17.90 
Total 
Charges 
($)* 
Unmatched 195702.47 66607.12 129095.35 4526.81 28.52   
ATT 193972.72 75482.31 118490.41 6902.44 17.17 9.50 
Survival to 
Discharge* 
Unmatched 0.91 0.76 0.15 0.02 6.95   
ATT 0.91 0.72 0.19 0.02 8.62 4.20 
*Survival probability 
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Table A-1: Systematic review study characteristics 
Study Design Source Population Study Population Relevant Outcomes 
Clec'h et 
al 2007 
Prospective, 
observational 
cohort 
OUTCOMEREA database: 
Randomly sampled from 
patients at least 16 yrs., ICU 
stays >24 hours at 12 French 
ICUs.  
MV at least 48 hours 
-Exclusion: Prior tracheostomy. 
-Primary: ICU and 
Hospital Mortality 
-Secondary: ICU 
and Hospital LOS, 
MV length 
Flaatten 
et al 2006 
Prospective 
cohort study 
Norwegian University 
Hospital ICU patients, 1997 
to 2003. 
MV >24  in ICU from 1997-2003.  
Indications: Anticipated prolonged 
endotracheal intubation and 
ventillation, or to secure the upper 
airway in a trauma. 
-Primary: ICU and 
Hospital Mortality 
-Secondary: ICU 
length of stay, 
Mechanical 
Ventilation Days 
Combes 
et al 2007 
Retrospective 
observational 
cohort and Case-
Control 
Admitted to a medical 
surgical ICU in France, 2002 
-2004  
Mechanically ventilated patients 
Exclusion:  Not tracheostomized at 
admission to the ICU later had 
tracheostomy placed  
-Primary: ICU and 
Hospital Mortality, 
ICU length of stay, 
Mechanical 
Ventilation Days 
Frutos-
Vivar et 
al 2005 
Prospective, 
observational 
cohort study 
Patients admitted to 361 
intensive care units from 12 
countries , March 1- March 
31 1998.. 
Patients mechanically ventilated >12 
hours.  
-Exclusion: Previous tracheostomy 
-Primary: ICU and 
Hospital Mortality, 
ICU and Hospital 
LOS 
Wu et al 
2010 
Retrospective 
observational 
cohort 
All patients transferred to 
Gang Chung Memorial 
Hospital Respiratory Care 
Center between November 
1999 and December 2005 
RCC patients not hemodynamically 
unnstable, no vasoactive drug infusion 
within 24 hours of transfer, stable O2 
requirement, no acute hepatic/renal 
failure, no surgical intervention needed 
within 2 weeks.  
-Exclusion: Any patient developing 
unstable O2 requiremetn or 
hepatic/renal failure. Terminal cancer 
patients and those given tracheostomy 
before RCC admission. Repeat 
admissions not included. 
-Primary: RCC and 
Hospital Mortality 
-Secondary: RCC 
and Hospital length 
of stay, Mechanical 
Ventilation Days 
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Table A-2: General Demographics 
  Clec'h et al 2007 Flaatten et al 2006 Combes et al 2007 Frutos-
Vivar et 
al 2005 * 
Wu et al 2010 
Tracheo
stomy 
Comparis
on 
Tracheo
stomy 
Compa
rison 
Tracheo
stomy 
Compa
rison 
Tracheo
stomy 
Tracheo
stomy 
Compa
rison 
Total N (%) 177 2009 461 855 166 340 64.50% 985 227 
Age Median or % 5%/53%/
42%* 
12%/48%
/40%* 
46.6 48.3 mean: 
59 
mean: 
59 
mean: 
59 
73.15 73.56 
p or (difference 
[95% CI]) 
0.02 (6.4 [3.8 - 9.0]) 0.97 SD: 17 0.73 
Male % 66% 64.50% --------- -------- 67% 70% 62.0% 56% 47% 
p 0.66 --------- -------- 0.47 --------- 0.02 
SAPS 
II 
Score 
unles
s 
noted 
Median or 
<36/36-57/>57 
28%/49
%/23% 
25%/43%
/32% 
46.6 48.3 mean: 
53  
+/- 16 
mean: 
53  
+/-17 
43 18.58 20.3 
p 0.64 [1.7(-0.2 to 3.6)]** 0.73 SD: 15 Apache II, <0.001 
Admis
sion 
Categ
ory 
Medical (%) 73% 66% 30.6 44.4 70% 67% 62% 91% 91% 
Scheduled/Any 
Surgical(%) 
12% 13% 62.7 51.9 14% 10% 37% 9% 9% 
Unscheduled 
Surgical(%) 
15% 21% --------- --------- 16% 23% ---------- --------- --------- 
p 0.1 --------- --------- 0.11 --------- ---------- 
* %/%/%: Clec'h: <40, 40-70, >70          **[difference (95% confidence interval) *** %/%/%: Clec'h: <40, 40-70, >70  
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Table A-3: Mortality Outcomes 
    Tracheostomy Comparison     
Endpoint % % OR* or Difference p [95% CI] 
Clec'h et al 
2007 
  
  
  
  
  
ICU 27.68% 37.15% 0.65 0.01 
Discharge 42.95% 41.98% 1.04 0.8 
ICU Adjusted All Patient ** ------------ ------------ 0.94, 1.12 0.74, 0.59 
Post ICU Adjusted All Patient 
** 
------------ ------------ 2.57, 2.12 0.01, 0.049 
Post ICU Adjusted, 
Decanulated by D/C** 
------------ ------------ 1.43, 0.86 0.56, 0.80 
Post ICU Adjusted, Discharge 
with tracheostomy** 
------------ ------------ 3.73, 4.63 0.008, 0.003 
Flaatten et al 
2006 
ICU 11.2% 29.0% ------------ ------------ 
Hospital 27.1% 36.8% ------------ ------------ 
90 Day 30.9% 40.5% ------------ ------------ 
SMR*** 69.0% 93.0% ------------ ------------ 
Combes et al 
2007 
ICU 33.0% 42.0% 0.68 0.06 
Hospital 37.0% 48.0% 0.64 0.03 
Matched ICU 33.0% 47.0% 0.56 0.02 
Matched Hospital 36.0% 50.0% 0.56 0.05 
Frutos-Vivar et 
al 2005 
ICU Mortality 20.0% 32.0% 0.53 <0.001 
Adjusted ICU Mortality ------------ ------------ 0.45 [1.72-2.86] 
Hospital 39.0% 40.0% 0.96 0.65 
Wu et al 2010 Hospital 30.76% 44.93% 0.54 <0.001 
% of hospital deaths in RCC 69.31% 67.65% 1.08 0.75 
Matched Hospital 14.73% 38.76% 0.27 0.08 
Matched % of hospital deaths 
in RCC 
63.16% 64.00% 0.96 0.72 
*Odds Ratios calculated for this table, **OR model 1/OR Model 2, ***SMR: Standardized Mortality Ratio calculated using 
SAPS II Equation 
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Table A-4: ICU Length of stay 
    Tracheostomy Control p 
  Days SD [95% CI] Days SD [95% CI] 
Clec'h et al 2007 Unadjusted 46 [29-67] 10 [6-18] <0.001 
Model 1 Adjusted* 45 [29-67] 20 [13-30] <0.001 
Flaatten et al 2006 Median 11.2   4     
Mean (difference) 14.8   5.5 9.3 [8.3-10.3]   
Combes et al 2007 Median 35 {24-52}** 11 {7-19}**   
Mean 41 27 15 14 <0.0001 
Matched Median 34 {23-51}** 18 {12-27}**   
Matched Mean 41 28 22 17 <0.0001 
Frutos-Vivar et al 
2005 
Median 21 {12-32}** 7 {4-12}** <0.001 
Wu et al 2010 Median 22 [0-151]*** 14 [0-151]*** <0.01 
Matched Median 28 [5-121]*** 16 [2-151]*** <0.01 
 *Model 2 results similar, **Interquartile ranges, not CI, ***Total range 
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Table A-5: Mechanical Ventilation Duration 
    Tracheostomy Control 95% CI 
Days SD [95% CI] Days SD [95% CI] p 
Clec'h et al 2007 Median 33 [22-54] 7 [3-13] <0.001 
Model 1 Adjusted* 44 [22-50] 17 [9-24] <0.001 
Flaatten et al 
2006 
Median 8.2   2.6     
Mean (Difference) 11.4   3.9 7.5 [6.6-10/3   
Combes et al 
2007 
Median 30 {20-40}** 8 {5-13}**   
Mean 35 25 12 11 <0.0001 
Matched Median 28 {19-40}** 13 {9-20}**   
Matched Mean 35 26 17 14 <0.0001 
Frutos-Vivar et al 
2005 
Median 14 {7-25}** 4 {3-8}** <0.001 
Wu et al 2010 Median 53 [8-246]*** 41 [0-216]*** <0.01 
Matched Median 55 [21-173]*** 44 [19-186]*** <0.01 
 *Model 2 results similar, **Interquartile ranges not CI, ***Total range 
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Table A-6: Hospital Stay 
    Tracheostomy Control 95% CI 
   Days SD [95% CI] Days SD [95% CI] p 
Clec'h et al 2007  
(post icu stay) 
Median 13* [1-35] 4* [1-17] <0.001 
Model 1 Adjusted* 13 [1-34] 7 [1-21] <0.001 
Flaatten et al 2006 Not Given           
Combes et al 2007 Not Given           
Frutos-Vivar et al 
2005 
Median 36 {23-53}** 15 {8-26}** <0.001 
Wu et al 2010 Median 82 [12-806]*** 64 [1-424]*** <0.01 
Matched Median 84 [32-806]** 72 [19-197]*** 0.04 
 *Days in Clec'h trial are post ICU stay, not total, **Interquartile ranges not CI, ***Total range 
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Table A-7: Evidence Quality 
Study Source 
Population 
Definition 
Study population 
representative of 
source 
Probability of 
Selection Bias 
Probability of 
Measurement 
Bias 
Analysis Probability 
of 
unadjusted 
confounder
s 
Internal 
Validit
y 
Generizability 
Clec'h et 
al 2007 
Fair Good Low-moderate Low Good Low Good Fair 
Flaatten et 
al 2006 
Good Good Moderate-high Low Poor-fair high Poor-
Fair 
Poor-fair 
Combes et 
al 2007 
Fair Full cohort: 
Good 
Matched: Fair 
Full cohort: 
Moderate 
Matched: Low-
moderate 
Low Good low-
moderate 
Fair-
good 
Fair-good 
Frutos-
Vivar et al 
2005 
Poor-fair Fair-Good Moderate Moderate Good Moderate Fair Fair 
Wu et al 
2010 
Good Full cohort: Fair-
good 
Matched: Poor-
fair 
Full cohort: High 
Matched: Low 
Moderate-low Fair-
Good 
Low-
moderate 
Fair Fair 
 
